Treatment of inflammatory bowel disease patients with anti-TNF-α factors and immunosuppressives does not influence the prevalence of Helicobacter pylori infection

Indian J Gastroenterol. 2014 Jul;33(4):383-4. doi: 10.1007/s12664-013-0389-z.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use*
  • Adult
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Female
  • Gastritis / complications
  • Gastritis / epidemiology*
  • Gastritis / microbiology*
  • Helicobacter Infections*
  • Helicobacter pylori*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Inflammatory Bowel Diseases / complications
  • Inflammatory Bowel Diseases / drug therapy*
  • Male
  • Middle Aged
  • Prevalence
  • Tumor Necrosis Factor-alpha / immunology*

Substances

  • Adrenal Cortex Hormones
  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha